A Biopharma Company Transforms Patient Care and Drug Development Using Patient Journey Analytics | a Success Story by Quantzig
A global data analytics and advisory firm, Quantzig, that delivers actionable analytics solutions to resolve complex business problems has announced the completion of their latest patient journey analytics engagement for a leading biopharma client. During the course of this engagement, the analytics experts at Quantzig adopted a comprehensive approach to assessing the qualitative and quantitative datasets to arrive at a better understanding of the needs and perceptions of their patients.
The healthcare sector is in the midst of a paradigm shift due to which healthcare players are moving away from fact-based decisions and are now relying on advanced analytics to make well-informed decisions. This has proved to be a major challenge for biopharma companies since most of them lack the basic capabilities and analytics skills to extract meaningful insights from patient data. Moreover, in a highly regulated environment like biopharma, analyzing patient journeys can make a significant difference which can make or break the success of their initiatives.
The Business Problem: The client is a well-known biopharma industry player based out of Denmark. They wanted to identify the feasible ways through which they could leverage patient journey analytics to assess the qualitative and quantitative patient data sets. This is when they approached Quantzig to leverage its analytics expertise to gain a comprehensive view of patient journeys and their satisfaction rates.
Our portfolio of patient journey analytics solutions will empower organizations to adopt a data-driven approach to overcome challenges arising due to unstructured datasets.
Get in touch with our experts to know more about the true potential of analytics in healthcare.
"Owing to the complexities in today's healthcare landscape its imperative for businesses to leverage patient journey modeling to transform patient experiences and drive the success of their drug launch initiatives," says a patient journey analytics expert from Quantzig.
The Solution Offered: To help the client analyze patient journeys, the analytics experts at Quantzig adopted a comprehensive approach that focused on leveraging natural language processing and advanced algorithms to analyze and extract meaningful insights from unstructured patient data. This, in turn, helped them identify the most efficient treatment pathways and drug launch initiatives based on the patient's experience.
Advanced analytics techniques and big data can help biopharma companies to improve treatments, drug effectiveness, and reduce risks. This success story is one such example where Quantzig 's patient journey analytics solutions helped a client to address their challenges by leveraging innovative analytics based methodologies. Request a free proposal to know how we can help you gain a leading edge in the healthcare market.
Quantzig's patient journey analytics solutions helped the client to:
- Categorize and prioritize patient groups
- Identify the potential benefits of new drugs
- Request a free demo to know how you can benefit from patient journey analytics.
Quantzig's patient journey analytics solutions offered predictive insights on:
- Leveraging real-time patient data to roll out new patient support programs
- Building action plans to address issues through patient journey mapping
- Patient journey analytics can help you map the patient's journey to identify new opportunities for growth. Request for more information now!
About Quantzig
Quantzig is a global analytics and advisory firm with offices in the US, UK, Canada, China, and India. For more than 15 years, we have assisted our clients across the globe with end-to-end data modeling capabilities to leverage analytics for prudent decision making. Today, our firm consists of 120+ clients, including 45 Fortune 500 companies. For more information on our engagement policies and pricing plans, visit: https://www.quantzig.com/request-for-proposal
News published on and distributed by:
